ArticleJournal of chemical information and modeling2026
Doing More with Less: Accurate and Scalable Ligand Free Energy Calculations by Focusing on the Binding Site.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Rational design of triazole tyrosinase inhibitors via integrated free energy calculations.Molecular diversity · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Predicting how chemical modifications affect drug binding is central to rational drug design. Free energy perturbation (FEP) calculations provide accurate estimates of these binding affinity changes, but existing methods often require substantial computational resources and expert knowledge. Here, we present QligFEP v2.1.0, a flexible open-source workflow based on a graphical and command-line interface for calculating relative binding free energies using spherical boundary conditions, which dramatically reduces simulation system size by confining simulations to a focused region around the binding site. QligFEP features a configurable restraint algorithm that automatically handles diverse chemical transformations, streamlined setup procedures, and enhanced analysis tools. We validated the method using industry benchmarks comprising 16 protein targets and 639 ligand transformations. Statistical analysis demonstrates that QligFEP achieves comparable accuracy to established commercial and open-source alternatives while requiring only a fraction of the computational resources. The perturbation protocol simulates ∼6250 atoms per perturbation leg and completes transformation replicates in under 2 h on standard computational clusters. Unlike full-system simulations, QligFEP's modest computational requirements make FEP accessible for less than $1 on current AWS spot instances. The combination of accuracy, flexibility, and computational efficiency positions QligFEP as a practical solution for accelerating compound optimization in drug discovery, making rigorous binding affinity predictions accessible for large scale applications and to research groups with limited computational infrastructure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.